Can Generative-Model-Based Drug Design Become a New Normal in Drug Discovery?
Journal:
Journal of medicinal chemistry
Published Date:
Dec 16, 2021
Abstract
It is still rare that AI application examples with full DMTA (Design, Make, Test, Analysis) outcomes are reported. A recent study highlights that a generative model could be applied in the drug discovery process through an example in which ideas generated by an AI generative model were confirmed by following wet-lab works.